Skip to main content

Remote Job Finders (RJF)

Lilly Dives Deeper Into Gene Therapy With up to $262M Adverum Buy

The cornerstone of the deal is Ixo-vec, an intravitreal gene therapy currently in Phase III development for wet age-related macular degeneration. Eli Lilly made another foray into genetic medicine in June, picking up Verve Therapeutics for up to $1.3 billion.

$17M in Tax Incentives Will Add 800 Life Sciences Jobs This Year in Massachusetts

Of the 25 companies receiving tax incentives in Massachusetts, 23 will add jobs outside of Boston and Cambridge. Medtronic, which is receiving the largest award, will create 220 roles in Billerica. Other recipients include AbbVie, Dyne Therapeutics and Viridian Therapeutics.
Scroll to top